{"disease":{"id":"onchocerciasis-ocular","name":"onchocerciasis ocular"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06070116","title":"Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04049630","title":"Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":255,"lead_sponsor_name":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","has_results":false},{"nct_id":"NCT04049851","title":"Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Center for Research on Filariasis and Other Tropical Diseases, Cameroon","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}